SG Americas Securities LLC Acquires 14,000 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

SG Americas Securities LLC boosted its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAYGet Rating) by 178.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 21,847 shares of the medical instruments supplier’s stock after buying an additional 14,000 shares during the period. SG Americas Securities LLC’s holdings in DENTSPLY SIRONA were worth $619,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in the business. Vanguard Group Inc. increased its position in DENTSPLY SIRONA by 2.0% in the 1st quarter. Vanguard Group Inc. now owns 24,333,490 shares of the medical instruments supplier’s stock worth $1,197,694,000 after buying an additional 477,563 shares during the period. Artisan Partners Limited Partnership increased its position in DENTSPLY SIRONA by 9.3% in the 2nd quarter. Artisan Partners Limited Partnership now owns 12,758,726 shares of the medical instruments supplier’s stock worth $455,869,000 after buying an additional 1,089,244 shares during the period. Price T Rowe Associates Inc. MD increased its position in DENTSPLY SIRONA by 10.0% in the 2nd quarter. Price T Rowe Associates Inc. MD now owns 9,987,997 shares of the medical instruments supplier’s stock worth $356,871,000 after buying an additional 905,001 shares during the period. Nuance Investments LLC increased its position in DENTSPLY SIRONA by 356.3% in the 2nd quarter. Nuance Investments LLC now owns 9,051,338 shares of the medical instruments supplier’s stock worth $323,404,000 after buying an additional 7,067,751 shares during the period. Finally, Wellington Management Group LLP increased its position in DENTSPLY SIRONA by 83.1% in the 1st quarter. Wellington Management Group LLP now owns 5,502,424 shares of the medical instruments supplier’s stock worth $270,829,000 after buying an additional 2,497,773 shares during the period. 98.52% of the stock is owned by institutional investors.

DENTSPLY SIRONA Price Performance

Shares of XRAY stock opened at $36.97 on Monday. The stock’s fifty day simple moving average is $32.15 and its 200 day simple moving average is $32.37. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.50 and a quick ratio of 1.04. The firm has a market cap of $7.95 billion, a price-to-earnings ratio of 13.85, a P/E/G ratio of 5.02 and a beta of 0.87. DENTSPLY SIRONA Inc. has a one year low of $26.48 and a one year high of $58.70.

DENTSPLY SIRONA (NASDAQ:XRAYGet Rating) last announced its quarterly earnings results on Monday, November 14th. The medical instruments supplier reported $0.41 EPS for the quarter, missing the consensus estimate of $0.59 by ($0.18). The company had revenue of $947.00 million during the quarter, compared to analyst estimates of $1.01 billion. DENTSPLY SIRONA had a negative net margin of 20.81% and a positive return on equity of 9.63%. DENTSPLY SIRONA’s quarterly revenue was down 8.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.68 EPS. On average, analysts expect that DENTSPLY SIRONA Inc. will post 1.96 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 13th. Shareholders of record on Friday, December 30th were paid a $0.125 dividend. This represents a $0.50 dividend on an annualized basis and a yield of 1.35%. The ex-dividend date was Thursday, December 29th.

Wall Street Analysts Forecast Growth

XRAY has been the topic of several recent analyst reports. TheStreet downgraded DENTSPLY SIRONA from a “c” rating to a “d” rating in a research report on Monday, November 14th. StockNews.com started coverage on DENTSPLY SIRONA in a research report on Wednesday, October 12th. They set a “hold” rating on the stock. William Blair upgraded DENTSPLY SIRONA from an “underperform” rating to a “market perform” rating in a research report on Wednesday, January 11th. Evercore ISI boosted their price objective on DENTSPLY SIRONA to $34.00 in a research report on Thursday, November 17th. Finally, UBS Group lowered their price objective on DENTSPLY SIRONA to $35.00 in a research report on Thursday, November 17th. Seven investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat, DENTSPLY SIRONA presently has an average rating of “Hold” and a consensus target price of $40.70.

About DENTSPLY SIRONA

(Get Rating)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products.

Recommended Stories

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAYGet Rating).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.